President Barack Obama signed into law last week an act that ensures drugs scheduled as controlled substances will get their full exclusivity. Under the Improving Regulatory Transparency for New Medical Therapies Act, a drug considered a controlled substance will not be deemed approved until an interim final rule scheduling the drug is issued.